1. Home
  2. WST vs HOLX Comparison

WST vs HOLX Comparison

Compare WST & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • HOLX
  • Stock Information
  • Founded
  • WST 1923
  • HOLX 1985
  • Country
  • WST United States
  • HOLX United States
  • Employees
  • WST N/A
  • HOLX N/A
  • Industry
  • WST Medical/Dental Instruments
  • HOLX Medical Electronics
  • Sector
  • WST Health Care
  • HOLX Health Care
  • Exchange
  • WST Nasdaq
  • HOLX Nasdaq
  • Market Cap
  • WST 15.6B
  • HOLX 14.5B
  • IPO Year
  • WST N/A
  • HOLX 1990
  • Fundamental
  • Price
  • WST $263.31
  • HOLX $66.50
  • Analyst Decision
  • WST Buy
  • HOLX Buy
  • Analyst Count
  • WST 7
  • HOLX 13
  • Target Price
  • WST $332.50
  • HOLX $76.18
  • AVG Volume (30 Days)
  • WST 852.1K
  • HOLX 1.9M
  • Earning Date
  • WST 07-24-2025
  • HOLX 07-30-2025
  • Dividend Yield
  • WST 0.33%
  • HOLX N/A
  • EPS Growth
  • WST N/A
  • HOLX 25.36
  • EPS
  • WST 6.68
  • HOLX 2.39
  • Revenue
  • WST $2,960,200,000.00
  • HOLX $4,026,500,000.00
  • Revenue This Year
  • WST $3.38
  • HOLX $2.99
  • Revenue Next Year
  • WST $5.82
  • HOLX $4.91
  • P/E Ratio
  • WST $39.42
  • HOLX $27.82
  • Revenue Growth
  • WST 2.90
  • HOLX 1.66
  • 52 Week Low
  • WST $187.43
  • HOLX $51.90
  • 52 Week High
  • WST $352.33
  • HOLX $84.67
  • Technical
  • Relative Strength Index (RSI)
  • WST 67.71
  • HOLX 61.90
  • Support Level
  • WST $206.80
  • HOLX $63.58
  • Resistance Level
  • WST $291.00
  • HOLX $64.64
  • Average True Range (ATR)
  • WST 8.40
  • HOLX 1.22
  • MACD
  • WST 4.53
  • HOLX 0.03
  • Stochastic Oscillator
  • WST 67.11
  • HOLX 85.42

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: